COVID-19 (novel Coronavirus) Billing, Coding, and Compliance Updates
Craneware supports all US healthcare providers during the Coronavirus pandemic
Please scroll down to access COVID-19 resources and guidance. Information on COVID-19 is rapidly changing and will be updated accordingly. All published updates were factual on the date that appears on the article.
COVID-19 (novel Coronavirus) Billing, Coding, and Compliance Updates
The media is closely reporting on efforts being taken across the United States to ramp up clinical operations to prepare for and respond to the influx of patients that will require specialized testing and treatment. Likewise, healthcare organizations are taking steps to create resiliency across financial operations to support their missions in the months to come. Your efforts are critically important.
Craneware’s data team is continuously monitoring guidance regarding billing and coding for COVID-19 testing and treatment. Please check back frequently for updated information.
Craneware customers and non-customers alike should feel free to contact support@craneware.com for questions related to COVID-19 billing and coding – we are here to serve in this unique and trying time.
Rapid Fire Q & A
- Has CMS published the payment rates for the new COVID-19 antibody laboratory CPT codes 86769 and 86328? Are these codes retroactive for Medicare? 20 May 2020
- If we make a patient’s home a temporary expansion site of our provider-based department (PBD), are we required to only append modifiers PO or PN to items and services that are reimbursed under the Outpatient Prospective Payment System (OPPS) or do these modifiers need to be appended to all claim line items? 18 May 2020
- Will CMS cover COVID-19 antibody lab tests when performed as part of pre-admission testing/screening for surgical patients? 15 May 2020
COVID-19 Regulatory Updates
Craneware has made the decision to publicly publish the following in-depth regulatory bulletins which are normally only available to our customers due to the unprecedented nature of the COVID-19 pandemic.
- CMS Interim Final Rule – Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency (PHE) 12 May 2020
- Rural Health Clinics (RHCs) and Federally Qualified Health Centers (FQHCs) – Expanded Flexibilities During COVID-19 Public Health Emergency 22 April 2020
- Revised-Medicare Fee-for-Service (FFS) Response to the Public Health Emergency on the Coronavirus (COVID-19) 20 April 2020
Additional Resources
Providing COVID-19 Expertise
CPT Codes © 2020 American Medical Association, use of this site denotes acceptance of below terms and conditions
CPT codes, descriptions, and material only are copyright 2020 American Medical Association (AMA). All Rights Reserved. No fee schedules, basic units, relative values or related listings are included in CPT. AMA does not directly or indirectly practice medicine or dispense medical services. AMA assumes no liability for data contained or not contained here in. CPT is a trademark of the American Medical Association.
The responsibility for the content of any ‘National Correct Coding Policy’ included in this product is with Centers for Medicare and Medicaid Services, formerly known as Health Care Financing Administration, and no endorsement by the AMA is intended or should be implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, nonuse or interpretation of information contained in this product.
This product includes CPT which is commercial technical data and/or computer data bases and/or commercial computer software and/or commercial computer software documentation, as applicable which were developed exclusively at private expense by the American Medical Association, 515 North State Street, Chicago, Illinois, 60610. U.S. Government rights to use, modify, reproduce, release, perform, display, or disclose these technical data and/or computer data bases and/or commercial computer software and/or commercial computer software documentation are subject to the limited rights restrictions of DFARS 252.227-7015(b)(2)(June 1995) and/or subject to the restrictions of DFARS 227.7202-1(a) (June 1995) and DFARS 227.7202-3(a) (June 1995), as applicable for U.S. Department of Defense procurements and the limited rights restrictions of FAR 52.227-14 (June 1987) and/or subject to the restricted rights provisions of FAR 52.227-14 (June 1987) and FAR 52.227-19 (June 1987), as applicable, and any applicable agency FAR Supplements, for non-Department of Defense Federal procurements.
Applicable FARS/DFARS Restrictions Apply to Government Use.